FirstHealth Moore Regional Hospital is seeking volunteers for a new oncology research study.
The purpose of the Alliance study is to find out what effects, good and/or bad, the investigational drug (cabozantinib) has on advanced or metastatic kidney cancer and to compare it to the current standard treatment (sunitinib).
To find out if you are eligible, or for more information on clinical trials offered at FirstHealth, call (910) 715-2200.
